Bypassing luminal barriers, delivery to a gut addressin by parenteral targeting elicits local IgA responses

International Immunology

Volumn 16, Issue 11, 2004, Pages 1613-1622

  McKenzie, Brent S ^a,e   Corbett, Alexandra J ^a   Johnson, Susan ^a   Brady, Jamie L ^a   Pleasance, Jill ^a   Kramer, David R ^b   Boyle, Jefferey S ^c   Jackson, David C ^d   Strugnell, Richard A ^d   Lew, Andrew M ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c CSL LIMITED   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adhesion molecules; Antigen targeting; Mucosa; Vaccination

Indexed keywords

ADDRESSIN; CYTOKINE; IMMUNOGLOBULIN A; MECA 367; MECA 89; MONOCLONAL ANTIBODY; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG TARGETING; DRUG TOLERANCE; GASTROINTESTINAL TRACT; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION MOLECULES; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULINS; INTESTINE, SMALL; MICE; MUCOPROTEINS; MUCOUS MEMBRANE; RATS; VACCINATION;

EID: 8344222997     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh163     Document Type: Article

References (41)

1. Czerkinsky, C., Anjuere, F., McGhee, J. R. et al. 1999. Mucosal immunity and tolerance: relevance to vaccine development. Immunol. Rev. 170:197.
2. Eriksson, K. and Holmgren, J. 2002. Recent advances in mucosal vaccines and adjuvants. Curr. Opin. Immunol. 14:666.
3. Ermak, T. H. and Giannasca, P. J. 1998. Microparticle targeting to M cells. Adv. Drug Deliv. Rev. 34:261.
4. Frey, A. and Neutra, M. R. 1997, Targeting of mucosal vaccines to Peyer's patch M cells. Behring Inst. Mitt. 376.
5. Faria, A. M. and Weiner, H. L. 1999. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73:153.
6. Bai, X. F. and Link, H. 2000. Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine. Clin. Exp. Allergy 30:1688.
7. Mowat, A. M. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3:331.
8. Ada, G. 2001. Vaccines and vaccination. N. Engl. J. Med. 345:1042.
9. Levine, M. M. 2003. Can needle-free administration of vaccines become the norm in global immunization? Nat. Med. 9:99.
10. John, T. J. and Jayabal, P. 1972. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am. J. Epidemiol. 96:263.
11. Hanlon, P., Hanlon, L., Marsh, V. et al. 1987. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1:1342.
12. Herremans, T. M., Reimerink, J. H., Buisman, A. M., Kimman, T. G. and Koopmans, M. P. 1999. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J. Immunol. 162:5011.
13. Kawabata, S., Terao, Y., Fujiwara, T., Nakagawa, I. and Hamada, S. 1999. Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice. Infect. Immun. 67:5863.
14. Lehner, T., Wang, Y., Cranage, M. et al. 1996. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat. Med. 2:767.
15. Medina, E. and Guzman, C. A. 2001. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 19:1573.
16. Mestecky, J., Michalek, S. M., Moldoveanu, Z. and Russell, M. W. 1997. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Behring Inst. Mitt. 33.
17. Elson, C. O. and Ealding, W. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133:2892.
18. Briskin, M., Winsor-Hines, D., Shyjan, A. et al. 1997. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151:97.
19. Streeter, P.R., Berg, E. L., Rouse, B. T., Bargatze, R. F. and Butcher, E. C. 1988. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 331:41.
20. Berlin, C., Berg, E. L., Briskin, M. J. et al. 1993. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185.
21. Boyle, J. S., Brady, J. L. and Lew, A. M. 1998. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392:408.
22. Grewal, H. M., Hemming Karlsen, T., Vetvik, H. et al. 2000. Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses. J. Immunol. Methods 239:53.
23. Kramer, D. R. and Cebra, J. J. 1995. Early appearance of natural mucosal IgA responses and germinal centers in suckling mice developing in the absence of maternal antibodies. J. Immunol. 154:2051.
24. Losonsky, G. A., Fantry, G. T., Reymann, M. and Lim, Y. 1999. Validation of a gastrointestinal explant system for measurement of mucosal antibody production. Clin. Diagn. Lab. Immunol. 6:803.
25. Julius, M. H., Simpson, E. and Herzenberg, L. A. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645.
26. Delacroix, D. L., Furtado-Barreira, G., de Hemptinne, B., Goudswaard, J., Dive, C. and Vaerman, J. P. 1983. The liver in the IgA secretory immune system. Dogs, but not rats and rabbits, are suitable models for human studies. Hepatology 3:980.
27. Meckelein, B., Externest, D., Schmidt, M. A. and Frey, A. 2003. Contribution of serum immunoglobulin transudate to the antibody immune status of murine intestinal secretions: influence of different sampling procedures. Clin. Diagn. Lab. Immunol. 10:831.
28. Neutra, M. R., Mantis, N. J. and Kraehenbuhl, J. P. 2001. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2:1004.
29. Balogh, P., Aydar, Y., Tew, J. G. and Szakal, A. K. 2002. Appearance and phenotype of murine follicular dendritic cells expressing VCAM-1. Anat. Rec. 268:160.
30. Kraal, G., Schornagel, K., Streeter, P. R., Holzmann, B. and Butcher, E. C. 1995. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am. J. Pathol. 147:763.
31. Yamamoto, S., Kiyono, H., Yamamoto, M. et al. 1997. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267.
32. Mowat, A. M., Maloy, K. J. and Donachie, A. M. 1993. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens. Immunology 80:527.
33. Belyakov, I. M., Moss, B., Strober, W. and Berzofsky, J. A. 1999. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc. Natl. Acad. Sci. USA 96:4512.
34. Yamamoto, M., Rennert, P., McGhee, J. R. et al. 2000. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract. J. Immunol. 164:5184.
35. Bajenoff, M., Granjeaud, S. and Guerder, S. 2003. The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation. J. Exp. Med. 198:715.
36. Hall, J. G. and Morris, B. 1965. The origin of the cells in the efferent lymph from a single lymph node. J. Exp. Med. 121:901.
37. Szabo, M. C., Butcher, E. C. and McEvoy, L. M. 1997. Specialization of mucosal follicular dendritic cells revealed by mucosal addressin-cell adhesion molecule-1 display. J. Immunol. 158:5584.
38. Valujskikh, A., Lantz, O., Celli, S., Matzinger, P. and Heeger, P. S. 2002. Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 3:844.
39. Kreisel, D., Krupnick, A. S., Balsara, K. R. et al. 2002. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J. Immunol. 169:6154.
40. Savinov, A. Y., Wong, F. S., Stonebraker, A. C. and Chervonsky, A. V. 2003. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J. Exp. Med. 197:643.
41. Veazey, R.S., Marx, P.A. and Lackner, A.A. 2001. The mucosal immune system: primary target for HIV infection and AIDS. Trends Immunol. 22:626.